Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 HKD | 0.00% | -3.48% | -7.29% |
04-25 | China Risun Group Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024 | CI |
04-01 | China Risun Group Limited Announces Management Changes | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.29% | 1.74B | - | ||
+5.31% | 106B | A- | ||
-6.47% | 63.94B | A- | ||
+72.86% | 49.34B | B | ||
+16.94% | 39.15B | B | ||
+5.28% | 32.86B | A- | ||
+14.48% | 20.29B | B- | ||
+15.10% | 17.21B | C+ | ||
+18.07% | 15.28B | B- | ||
+4.83% | 14.58B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1907 Stock
- Ratings China Risun Group Limited